These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 6313385)

  • 1. Apomorphine separates the antinociceptive effects of cholecystokinin octapeptide and ceruletide from those of morphine.
    Zetler G
    Eur J Pharmacol; 1983 Aug; 92(1-2):151-4. PubMed ID: 6313385
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuroleptic-like effects of ceruletide and cholecystokinin octapeptide: interactions with apomorphine, methylphenidate and picrotoxin.
    Zetler G
    Eur J Pharmacol; 1983 Oct; 94(3-4):261-70. PubMed ID: 6140174
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CCK receptor activation may prevent tolerance to morphine in mice.
    Rezayat M; Nikfar S; Zarrindast MR
    Eur J Pharmacol; 1994 Mar; 254(1-2):21-6. PubMed ID: 8206114
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clonidine and yohimbine separate the sedation and the ptosis caused by cholecystokinin octapeptide and ceruletide.
    Zetler G
    Eur J Pharmacol; 1984 Jul; 102(2):333-40. PubMed ID: 6090162
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of cholecystokinin octapeptide and ceruletide on release of acetylcholine from cerebral cortex of the rat in vivo.
    Magnani M; Mantovani P; Pepeu G
    Neuropharmacology; 1984 Nov; 23(11):1305-9. PubMed ID: 6098846
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antistereotypic effects of cholecystokinin octapeptide (CCK-8), ceruletide and related peptides on apomorphine-induced gnawing in sensitized mice.
    Zetler G
    Neuropharmacology; 1985 Mar; 24(3):251-9. PubMed ID: 2859544
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential effects of sulfated cholecystokinin octapeptide and proglumide injected intrathecally on antinociception induced by beta-endorphin and morphine administered intracerebroventricularly in mice.
    Suh HH; Tseng LF
    Eur J Pharmacol; 1990 Apr; 179(3):329-38. PubMed ID: 2142090
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological properties of ceruletide in the vertical and horizontal locomotor activities of mice.
    Itoh T; Murai S; Masuda Y; Abe E; Ohkubo N; Itsukaichi O; Shoji S
    Pharmacol Biochem Behav; 1992 Oct; 43(2):571-6. PubMed ID: 1438494
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cholecystokinin octapeptide and caerulein injection into the dorsomedial nucleus accumbens potentiate apomorphine-induced jaw movements in rats.
    Koshikawa N; Kikuchi de Beltrán K; Saigusa T; Kobayashi M; Stephenson JD
    Eur J Pharmacol; 1991 Dec; 209(1-2):75-80. PubMed ID: 1814762
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Caerulein and morphine: an attempt to differentiate their antinociceptive effects.
    Zetler G
    Pharmacology; 1982; 25(3):121-9. PubMed ID: 7146080
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A behavioral pharmacological study on CCK-8 related peptides in mice.
    Moroji T; Hagino Y
    Neuropeptides; 1986 Oct; 8(3):273-86. PubMed ID: 3785587
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of cholecystokinin receptors in induction of antinociception in hot-plate test.
    Rezayat M; Rahnavard A; Zarrindast MR
    Pharmacol Toxicol; 2000 Aug; 87(2):58-62. PubMed ID: 10989941
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cholecystokinin octapeptide (CCK-8), ceruletide and analogues of ceruletide: effects on tremors induced by oxotremorine, harmine and ibogaine. A comparison with prolyl-leucylglycine amide (MIF), anti-Parkinsonian drugs and clonazepam.
    Zetler G
    Neuropharmacology; 1983 Jun; 22(6):757-66. PubMed ID: 6310434
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of ceruletide and cholecystokinin octapeptide on eating in mice. Interactions with naloxone and the enkephalin analogue, FK 33-824.
    Zetler G; Mörsdorf KH
    Naunyn Schmiedebergs Arch Pharmacol; 1984 Mar; 325(3):209-13. PubMed ID: 6328330
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ceruletide, ceruletide analogues and cholecystokinin octapeptide (CCK-8): effects on isolated intestinal preparations and gallbladders of guinea pigs and mice.
    Zetler G
    Peptides; 1984; 5(4):729-36. PubMed ID: 6093075
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The novel CCK antagonist L364,718 abolished caerulein- but potentiates morphine-induced antinociception.
    Rattray M; Jordan CC; De Belleroche J
    Eur J Pharmacol; 1988 Jul; 152(1-2):163-6. PubMed ID: 3208830
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cholecystokinin octapeptide, caerulein and caerulein analogues: effects on thermoregulation in the mouse.
    Zetler G
    Neuropharmacology; 1982 Aug; 21(8):795-801. PubMed ID: 6289160
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of apomorphine on the antinociceptive activity of morphine.
    Dunai-Kovács Z; Székely JI
    Psychopharmacology (Berl); 1977 Jun; 53(1):65-72. PubMed ID: 18752
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analgesic effect of intrathecal morphine demonstrated in ascending nociceptive activity in the rat spinal cord an in effectiveness of caerulein and cholecystokinin octapeptide.
    Doi T; Jurna I
    Brain Res; 1982 Feb; 234(2):399-407. PubMed ID: 6277433
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antinociceptive action of cholecystokinin octapeptide (CCK 8) and related peptides in rats and mice: effects of naloxone and peptidase inhibitors.
    Hill RG; Hughes J; Pittaway KM
    Neuropharmacology; 1987 Apr; 26(4):289-300. PubMed ID: 3295578
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.